CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 106 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,906,455 | +310.7% | 798,555 | +201.6% | 0.00% | +200.0% |
| Q2 2023 | $2,898,837 | +763.9% | 264,734 | +588.0% | 0.00% | – |
| Q1 2023 | $335,546 | +54.8% | 38,480 | +11.3% | 0.00% | – |
| Q4 2022 | $216,729 | +79.1% | 34,566 | 0.0% | 0.00% | – |
| Q3 2022 | $121,000 | -16.0% | 34,566 | -28.9% | 0.00% | – |
| Q2 2022 | $144,000 | -80.6% | 48,612 | -79.7% | 0.00% | – |
| Q1 2022 | $744,000 | +22.2% | 239,215 | +32.9% | 0.00% | – |
| Q4 2021 | $609,000 | -4.1% | 179,959 | +3.4% | 0.00% | – |
| Q3 2021 | $635,000 | -72.6% | 173,959 | -67.3% | 0.00% | -100.0% |
| Q2 2021 | $2,317,000 | -5.4% | 531,334 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $2,448,000 | -18.0% | 539,114 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $2,984,000 | -20.8% | 519,693 | -0.1% | 0.00% | -50.0% |
| Q3 2020 | $3,768,000 | +147.6% | 520,418 | +19.4% | 0.00% | +100.0% |
| Q2 2020 | $1,522,000 | +173.7% | 435,930 | +16.2% | 0.00% | – |
| Q1 2020 | $556,000 | -23.3% | 375,265 | +1.5% | 0.00% | – |
| Q4 2019 | $725,000 | -63.8% | 369,704 | -5.5% | 0.00% | -100.0% |
| Q3 2019 | $2,003,000 | -28.8% | 391,098 | -0.5% | 0.00% | -50.0% |
| Q2 2019 | $2,815,000 | -41.9% | 393,123 | +7.7% | 0.00% | -33.3% |
| Q1 2019 | $4,847,000 | +90.3% | 364,918 | +12.8% | 0.00% | +50.0% |
| Q4 2018 | $2,547,000 | -29.4% | 323,599 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $3,609,000 | +106.6% | 325,651 | +150.2% | 0.00% | +100.0% |
| Q2 2018 | $1,747,000 | +559.2% | 130,165 | +539.2% | 0.00% | – |
| Q1 2018 | $265,000 | +130.4% | 20,365 | +63.4% | 0.00% | – |
| Q4 2017 | $115,000 | – | 12,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |